Casdin Capital 组合持仓
Casdin Capital 13F filer (CIK 0001534261).
Q2 2026 · 42 个持仓 · 总申报市值 $2.00B · 前十大集中度 77.4%
换手率： 24.4% · 5 新建 · 3 减仓 · 3 清仓
主动份额（对标 S&P 500）： 99.8% · 对比 QQQ： 99.9% — 组合中区别于指数权重的部分（越高越主动） · 排名
在 Q2 2026 的 13F 申报中，Casdin Capital 披露了 42 个股票持仓，合计申报市值 $2.00B。前十大持仓占申报市值的 77.4%，组合属于集中型。HoldingsHub 将其风格标签归纳为 Mid / Focused / Health Tilt / High Turnover。
截至 Q2 2026，最大的披露持仓包括 RVMD（$482.68M）、RLAY（$300.02M）、WGS（$254.50M）。行业分布上，占比最高的板块为 Health Care 94.3%, 工业 5.7%。较上一季度，板块上主要增配 Health Care（+5.2 个百分点），同时减配 Technology（-1.0 个百分点）、Industrials（-4.2 个百分点）。
与上一季度相比，Casdin Capital 新建 5 个仓位、减持 3 个、清仓 3 个，换手率约 24.4%。持仓组合与上季度的重合率约为 82%。
以上数据来自该基金的 SEC 13F 申报。13F 需在季度结束后 45 天内提交，仅涵盖 10 万美元以上的多头持仓，不含空头与非 13F 资产类别，因此本页反映的是季末快照，并非基金的实时持仓。
| # | 代码 | 公司 | 股数 | 市值 | 权重 | 变动 |
|---|---|---|---|---|---|---|
| 1 | RVMD | REVOLUTION MEDICINES INC | 2.58M | $482.68M | 24.18% | 持有 |
| 2 | RLAY | RELAY THERAPEUTICS INC | 16.04M | $300.02M | 15.03% | 增持 |
| 3 | WGS | GENEDX HOLDINGS CORP | 3.71M | $254.50M | 12.75% | 增持 |
| 4 | BLFS | BIOLIFE SOLUTIONS INC | 4.66M | $131.46M | 6.58% | 减持 |
| 5 | ILMN | ILLUMINA INC | 530.00K | $93.19M | 4.67% | 持有 |
| 6 | LAB | STANDARD BIOTOOLS INC | 88.78M | $73.04M | 3.66% | 持有 |
| 7 | GPCR | STRUCTURE THERAPEUTICS INC | 1.18M | $63.06M | 3.16% | 持有 |
| 8 | DNLI | DENALI THERAPEUTICS INC | 2.04M | $52.60M | 2.63% | 增持 |
| 9 | NGNE | NEUROGENE INC | 1.55M | $48.60M | 2.43% | 增持 |
| 10 | BEAM | BEAM THERAPEUTICS INC | 1.35M | $46.33M | 2.32% | 持有 |
| 11 | TXG | 10X GENOMICS INC | 1.05M | $40.26M | 2.02% | 减持 |
| 12 | SRRK | SCHOLAR ROCK HLDG CORP | 665.00K | $36.58M | 1.83% | 增持 |
| 13 | PSNL | PERSONALIS INC | 2.55M | $34.17M | 1.71% | 增持 |
| 14 | GRAL | GRAIL INC | 480.00K | $32.77M | 1.64% | 增持 |
| 15 | GH | GUARDANT HEALTH INC | 185.00K | $27.76M | 1.39% | 减持 |
| 16 | MAZE | MAZE THERAPEUTICS INC | 843.86K | $25.18M | 1.26% | 增持 |
| 17 | HIMS | HIMS & HERS HEALTH INC | 700.00K | $24.27M | 1.22% | 持有 |
| 18 | ALNY | ALNYLAM PHARMACEUTICALS INC | 75.00K | $22.58M | 1.13% | 持有 |
| 19 | TSHA | TAYSHA GENE THERAPIES INC | 3.25M | $22.13M | 1.11% | 持有 |
| 20 | AGMB | AGOMAB THERAPEUTICS NV | 1.55M | $20.12M | 1.01% | 持有 |
| 21 | SEPN | SEPTERNA INC | 553.27K | $18.53M | 0.93% | 持有 |
| 22 | PBLS | PARABILIS MEDICINES INC | 645.69K | $17.67M | 0.89% | 新建 |
| 23 | SION | SIONNA THERAPEUTICS INC | 400.00K | $17.60M | 0.88% | 新建 |
| 24 | VCYT | VERACYTE INC | 276.31K | $16.23M | 0.81% | 持有 |
| 25 | ANL | ADLAI NORTYE LTD | 1.25M | $14.38M | 0.72% | 增持 |
| 26 | PRME | PRIME MEDICINE INC | 3.17M | $11.69M | 0.58% | 持有 |
| 27 | ABSI | ABSCI CORPORATION | 973.26K | $11.28M | 0.56% | 持有 |
| 28 | DGX | QUEST DIAGNOSTICS INCORPORATED | 50.00K | $10.60M | 0.53% | 持有 |
| 29 | SRPT | SAREPTA THERAPEUTICS INC | 470.00K | $8.45M | 0.42% | 新建 |
| 30 | QURE | UNIQURE NV | 150.00K | $6.91M | 0.35% | 新建 |
| 31 | NTLA | INTELLIA THERAPEUTICS INC | 355.00K | $6.01M | 0.30% | 持有 |
| 32 | MRNA | MODERNA INC | 75.00K | $5.25M | 0.26% | 持有 |
| 33 | IRON | DISC MEDICINE INC | 65.00K | $4.75M | 0.24% | 持有 |
| 34 | GLUE | MONTE ROSA THERAPEUTICS INC | 186.01K | $4.50M | 0.23% | 持有 |
| 35 | IPSC | CENTURY THERAPEUTICS INC | 1.23M | $3.01M | 0.15% | 持有 |
| 36 | CTNM | CONTINEUM THERAPEUTICS INC | 148.33K | $2.43M | 0.12% | 持有 |
| 37 | BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | 282.31K | $2.15M | 0.11% | 持有 |
| 38 | EDIT | EDITAS MEDICINE INC | 445.00K | $1.44M | 0.07% | 新建 |
| 39 | PACB | PACIFIC BIOSCIENCES CALIF IN | 723.77K | $1.22M | 0.06% | 持有 |
| 40 | RXRX | RECURSION PHARMACEUTICALS IN | 165.32K | $606.74K | 0.03% | 持有 |
| 41 | DNA | GINKGO BIOWORKS HOLDINGS INC | 36.49K | $361.65K | 0.02% | 持有 |
| 42 | TNYA | TENAYA THERAPEUTICS INC | 361.97K | $267.53K | 0.01% | 持有 |